Plain-English translation of NCT05175885 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new medical device called the Ark Kidney, which is a portable machine designed to keep donated kidneys alive and healthy while they wait to be transplanted into patients. Instead of storing kidneys cold (the traditional way), this machine continuously perfuses the kidney with warm, oxygenated blood to help it recover and stay viable. The study will compare how well kidneys perform when treated with this new machine compared to the traditional cold storage method.
Many donated kidneys today are stored in cold conditions, which can damage them and reduce how long they function after transplant. This new treatment aims to improve kidney quality and survival by keeping them warm and actively perfused, potentially giving transplant patients better long-term outcomes.
You likely qualify if…
You likely don't qualify if…
If you qualify and are selected, your donated kidney would be treated with the Ark Kidney machine before being transplanted into you. You would undergo the transplant surgery as planned, and then the research team would monitor your kidney function and overall health for one year after the transplant. During this year, you would have regular follow-up visits and blood tests to track how well your new kidney is working compared to kidneys treated with the traditional cold storage method.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Spain
Sponsor
Ebers Medical Technology, S.L.
Enrollment target
~100 participants
Started
December 2023
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pedro Moreo Calvo, PhD
Miguel Servet University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.